Tempest Therapeutics, Inc. (TPST)
NASDAQ: TPST · Real-Time Price · USD
1.000
+0.059 (6.26%)
At close: Nov 5, 2024, 4:00 PM
1.010
+0.010 (1.00%)
After-hours: Nov 5, 2024, 4:59 PM EST
Tempest Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 5, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 27 | 85 | 12 | 36 | - | - |
| Market Cap Growth | 230.66% | 600.22% | -66.85% | - | - | - |
| Enterprise Value | 14 | 95 | -14 | -4 | - | - |
| Last Close Price | 0.94 | 4.40 | 1.15 | 5.28 | - | - |
| PE Ratio | - | -2.30 | -0.37 | -0.71 | - | - |
| PB Ratio | 1.36 | 3.16 | 0.67 | 1.01 | - | - |
| P/FCF Ratio | -1.89 | -3.08 | -0.38 | -1.40 | - | - |
| P/OCF Ratio | -1.92 | -3.10 | -0.39 | -1.41 | - | - |
| EV/EBITDA Ratio | -1.17 | -3.29 | 0.41 | 0.17 | - | - |
| EV/EBIT Ratio | -1.16 | -3.24 | 0.40 | 0.16 | - | - |
| EV/FCF Ratio | -1.42 | -3.44 | 0.44 | 0.17 | - | - |
| Debt / Equity Ratio | 1.20 | 0.77 | 1.22 | 0.51 | 0.14 | 1.47 |
| Debt / FCF Ratio | -0.79 | -0.75 | -0.70 | -0.71 | -0.13 | -0.10 |
| Quick Ratio | 2.14 | 4.17 | 4.29 | 2.59 | 5.84 | 0.90 |
| Current Ratio | 2.17 | 4.29 | 4.53 | 3.44 | 6.15 | 1.04 |
| Return on Equity (ROE) | -289.26% | -131.42% | -131.70% | -104.76% | -196.78% | - |
| Return on Assets (ROA) | -54.28% | -37.31% | -36.29% | -35.10% | -79.27% | - |
| Return on Capital (ROIC) | -62.14% | -41.58% | -45.64% | -44.97% | -99.17% | - |
| Earnings Yield | -126.99% | -34.82% | -295.25% | -77.57% | - | - |
| FCF Yield | -103.12% | -32.50% | -261.55% | -71.51% | - | - |
| Buyback Yield / Dilution | -42.10% | -33.49% | -204.70% | -709.62% | 44.17% | - |
| Total Shareholder Return | -42.10% | -33.49% | -204.70% | -709.62% | 44.17% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.